Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

Chief Executive Officer

President and Chief Executive

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inh...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-11-27	Premium	sold	Premium	Premium	Premium	-
2023-11-27	Premium	sold	Premium	Premium	Premium	-
2023-11-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-11-15	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-08-11	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-05-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-05-15	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-11-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-11-15	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-10-04	Premium	bought	Premium	Premium	Premium	-
2022-09-26	Premium	bought	Premium	Premium	Premium	-
2022-08-03	Premium	sold	Premium	Premium	Premium	-
2022-08-03	Premium	sold	Premium	Premium	Premium	-
2022-08-02	Premium	sold	Premium	Premium	Premium	-
2022-08-02	Premium	sold	Premium	Premium	Premium	-
2022-08-01	Premium	sold	Premium	Premium	Premium	-
2022-08-01	Premium	sold	Premium	Premium	Premium	-
2022-07-28	Premium	sold	Premium	Premium	Premium	-
2022-07-28	Premium	sold	Premium	Premium	Premium	-
2022-07-27	Premium	sold	Premium	Premium	Premium	-
2022-07-27	Premium	sold	Premium	Premium	Premium	-
2022-07-26	Premium	sold	Premium	Premium	Premium	-
2022-07-26	Premium	sold	Premium	Premium	Premium	-
2022-07-25	Premium	sold	Premium	Premium	Premium	-
2022-07-25	Premium	sold	Premium	Premium	Premium	-

EFTR - eFFECTOR Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for EFTR